The association between delusional-like experiences, and tobacco, alcohol or cannabis use: A nationwide population-based survey

BMC Psychiatry

Volumn 11, Issue , 2011, Pages

  Saha, Sukanta ^a   Scott, James G ^a,b,c,d   Varghese, Daniel ^e   Degenhardt, Louisa ^f   Slade, Tim ^f   McGrath, John J ^a,d  

^a QUEENSLAND CENTRE FOR MENTAL HEALTH RESEARCH   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e PRINCESS ALEXANDRA HOSPITAL   (Australia)

^f UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Alcohol use or dependence; Cannabis; Delusional like experiences; Smoking

Indexed keywords

ADOLESCENT; ADULT; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; CANNABIS ADDICTION; CIGARETTE SMOKING; DELUSION; DELUSIONAL LIKE EXPERIENCE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PSYCHOSIS; SUBSTANCE ABUSE; ADDICTION; AGED; CANNABIS SMOKING; DRINKING BEHAVIOR; LONGITUDINAL STUDY; MIDDLE AGED; PREVALENCE; PSYCHOLOGICAL ASPECT; SMOKING;

CANNABIS;

ADOLESCENT; ADULT; AGED; ALCOHOL DRINKING; ALCOHOL-RELATED DISORDERS; CANNABIS; DELUSIONS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MARIJUANA SMOKING; MIDDLE AGED; PREVALENCE; PSYCHOTIC DISORDERS; SMOKING; SUBSTANCE-RELATED DISORDERS;

EID: 84455193321     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-11-202     Document Type: Article

References (48)

1. Hall W, Degenhardt L. Cannabis and the increased incidence and persistence of psychosis. BMJ 2011, 342:d719. 10.1136/bmj.d719, 21363867.
2. Degenhardt L, Hall WD, Lynskey M, McGrath J, McLaren J, Calabria B, Whiteford H, Vos T. Should burden of disease estimates include cannabis use as a risk factor for psychosis?. PLoS Med 2009, 6:e1000133. 10.1371/journal.pmed.1000133, 2741573, 19787023.
3. Arseneault L, Cannon M, Witton J, Murray RM. Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry 2004, 184:110-117. 10.1192/bjp.184.2.110, 14754822.
4. McGrath J, Welham J, Scott J, Varghese D, Degenhardt L, Hayatbakhsh MR, Alati R, Williams GM, Bor W, Najman JM. Association between cannabis use and psychosis-related outcomes using sibling pair analysis in a cohort of young adults. Arch Gen Psychiatry 2010, 67:440-447. 10.1001/archgenpsychiatry.2010.6, 20194820.
5. Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, Burke M, Lewis G. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007, 370:319-328. 10.1016/S0140-6736(07)61162-3, 17662880.
6. van Os J, Bak M, Hanssen M, Bijl RV, de Graaf R, Verdoux H. Cannabis use and psychosis: a longitudinal population-based study. Am J Epidemiol 2002, 156:319-327. 10.1093/aje/kwf043, 12181101.
7. Semple DM, McIntosh AM, Lawrie SM. Cannabis as a risk factor for psychosis: systematic review. J Psychopharmacol 2005, 19:187-194. 10.1177/0269881105049040, 15871146.
8. Zammit S, Allebeck P, Andreasson S, Lundberg I, Lewis G. Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. BMJ 2002, 325:1199. 10.1136/bmj.325.7374.1199, 135490, 12446534.
9. Large M, Sharma S, Compton MT, Slade T, Nielssen O. Cannabis Use and Earlier Onset of Psychosis: A Systematic Meta-analysis. Arch Gen Psychiatry 2011, 68:555-561. 10.1001/archgenpsychiatry.2011.5, 21300939.
10. Scott J, Martin G, Bor W, Sawyer M, Clark J, McGrath J. The prevalence and correlates of hallucinations in Australian adolescents: results from a national survey. Schizophr Res 2009, 107:179-185. 10.1016/j.schres.2008.11.002, 19046858.
11. Hides L, Lubman DI, Buckby J, Yuen HP, Cosgrave E, Baker K, Yung AR. The association between early cannabis use and psychotic-like experiences in a community adolescent sample. Schizophr Res 2009, 112:130-135. 10.1016/j.schres.2009.04.001, 19428219.
12. Miettunen J, Tormanen S, Murray GK, Jones PB, Maki P, Ebeling H, Moilanen I, Taanila A, Heinimaa M, Joukamaa M, Veijola J. Association of cannabis use with prodromal symptoms of psychosis in adolescence. Br J Psychiatry 2008, 192:470-471. 10.1192/bjp.bp.107.045740, 18515902.
13. Stefanis NC, Delespaul P, Henquet C, Bakoula C, Stefanis CN, Van Os J. Early adolescent cannabis exposure and positive and negative dimensions of psychosis. Addiction 2004, 99:1333-1341. 10.1111/j.1360-0443.2004.00806.x, 15369572.
14. Verdoux H, Tournier M, Cougnard A. Impact of substance use on the onset and course of early psychosis. Schizophr Res 2005, 79:69-75. 10.1016/j.schres.2004.12.008, 16198239.
15. Degenhardt L, Hall W. The association between psychosis and problematical drug use among Australian adults: findings from the National Survey of Mental Health and Well-Being. Psychological Medicine 2001, 31:659-668.
16. van Gastel WA, Wigman JTW, Monshouwer K, Kahn RS, van Os J, Boks MP, Vollebergh WAM. Cannabis use and subclinical positive psychotic experiences in early adolescents. Addicition
17. Schubart CD, van Gastel WA, Breetvelt EJ, Beetz SL, Ophoff RA, Sommer IE, Kahn RS, Boks MP. Cannabis use at a younger age is associated with psychotic experiences. Psychol Med 2011, 41:1301-1310.
18. Sorensen HJ, Mortensen EL, Reinisch JM, Mednick SA. A prospective study of smoking in young women and risk of later psychiatric hospitalization. Nord J Psychiatry 2011, 65:3-8. 10.3109/08039481003786386, 20429749.
19. Weiser M, Reichenberg A, Grotto I, Yasvitzky R, Rabinowitz J, Lubin G, Nahon D, Knobler HY, Davidson M. Higher rates of cigarette smoking in male adolescents before the onset of schizophrenia: a historical-prospective cohort study. Am J Psychiatry 2004, 161:1219-1223. 10.1176/appi.ajp.161.7.1219, 15229054.
20. Wiles NJ, Zammit S, Bebbington P, Singleton N, Meltzer H, Lewis G. Self-reported psychotic symptoms in the general population: results from the longitudinal study of the British National Psychiatric Morbidity Survey. Br J Psychiatry 2006, 188:519-526. 10.1192/bjp.bp.105.012179, 16738341.
21. Perala J, Kuoppasalmi K, Pirkola S, Harkanen T, Saarni S, Tuulio-Henriksson A, Viertio S, Latvala A, Koskinen S, Lonnqvist J, Suvisaari J. Alcohol-induced psychotic disorder and delirium in the general population. Br J Psychiatry 2010, 197:200-206. 10.1192/bjp.bp.109.070797, 20807964.
22. Slade T, Johnston A, Oakley Browne MA, Andrews G, Whiteford H. 2007 National Survey of Mental Health and Wellbeing: methods and key findings. Australian and New Zealand Journal of Psychiatry 2009, 43:594-605. 10.1080/00048670902970882, 19530016.
23. Australian Bureau of Statistics (ABS) 4327.0 - National Survey of Mental Health and Wellbeing: Users' Guide, 2007 2009, Canberra: Commonwealth Government of Australia, Australian Bureau of Statistics (ABS).
24. Jablensky A, McGrath J, Herrman H, Castle D, Gureje O, Morgan V, Korten A. People living with psychotic illness: An Australian study 1997-98 1999, Commonwealth of Australia.
25. Saha S, Scott J, Varghese D, McGrath J. The association between physical health and delusional-like experiences: a general population study. PLoS ONE 2011, 6:e18566. 10.1371/journal.pone.0018566, 3081831, 21541344.
26. Saha S, Scott JG, Varghese D, McGrath JJ. The association between general psychological distress and delusional-like experiences: a large population-based study. Schizophr Res 2011, 127:246-251. 10.1016/j.schres.2010.12.012, 21239145.
27. Saha S, Varghese D, Slade T, Degenhardt L, Mills K, McGrath J, Scott J. The association between trauma and delusional-like experiences. Psychiatry Res 2011, 189:259-264. 10.1016/j.psychres.2011.03.019, 21524800.
28. Varghese D, Scott J, Welham J, Bor W, Najman J, O'Callaghan M, Williams G, McGrath J. Psychotic-like experiences in major depression and anxiety disorders: a population based survey in young adults. Schizophrenia Bulletin 2009, 37:389-393. 3044630, 19687152.
29. Teesson M, Hall W, Slade T, Mills K, Grove R, Mewton L, Baillie A, Haber P. Prevalence and correlates of DSM-IV alcohol abuse and dependence in Australia: findings of the 2007 National Survey of Mental Health and Wellbeing. Addiction 2010, 105:2085-2094. 10.1111/j.1360-0443.2010.03096.x, 20707771.
30. Scott J, Welham J, Martin G, Bor W, Najman J, O'Callaghan M, Williams G, Aird R, McGrath J. Demographic correlates of psychotic-like experiences in young Australian adults. Acta Psychiatr Scand 2008, 118:230-237. 10.1111/j.1600-0447.2008.01214.x, 18518864.
31. Varghese D, Scott J, McGrath J. Correlates of delusion-like experiences in a non-psychotic community sample. Aust N Z J Psychiatry 2008, 42:505-508. 10.1080/00048670802050595, 18465377.
32. Rust KF, Rao JN. Variance estimation for complex surveys using replication techniques. Statistical Methods in Medical Research 1996, 5:283-310. 10.1177/096228029600500305, 8931197.
33. An AB. Performing logistic regression on survey data with the new SURVEYLOGISTIC procedure. Proceedings of the Twenty-Seventh Annual SAS® Users Group International Conference 258-27.
34. Ziedonis DM, George TP. Schizophrenia and nicotine use: report of a pilot smoking cessation program and review of neurobiological and clinical issues. Schizophr Bull 1997, 23:247-254.
35. Pontieri FE, Tanda G, Orzi F, Di Chiara G. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 1996, 382:255-257. 10.1038/382255a0, 8717040.
36. Sacco KA, Bannon KL, George TP. Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders. J Psychopharmacol 2004, 18:457-474. 10.1177/0269881104047273, 1201375, 15582913.
37. Picciotto MR. Nicotine as a modulator of behavior: beyond the inverted U. Trends Pharmacol Sci 2003, 24:493-499. 10.1016/S0165-6147(03)00230-X, 12967775.
38. Casadio P, Fernandes C, Murray RM, Di Forti M. Cannabis use in young people: the risk for schizophrenia. Neurosci Biobehav Rev 2011, 35:1779-1787. 10.1016/j.neubiorev.2011.04.007, 21530584.
39. Bhattacharyya S, Fusar-Poli P, Borgwardt S, Martin-Santos R, Nosarti C, O'Carroll C, Allen P, Seal ML, Fletcher PC, Crippa JA, et al. Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis. Arch Gen Psychiatry 2009, 66:442-451. 10.1001/archgenpsychiatry.2009.17, 19349314.
40. Fusar-Poli P, Crippa JA, Bhattacharyya S, Borgwardt SJ, Allen P, Martin-Santos R, Seal M, Surguladze SA, O'Carrol C, Atakan Z, et al. Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing. Arch Gen Psychiatry 2009, 66:95-105. 10.1001/archgenpsychiatry.2008.519, 19124693.
41. Bhattacharyya S, Crippa JA, Martin-Santos R, Winton-Brown T, Fusar-Poli P. Imaging the neural effects of cannabinoids: current status and future opportunities for psychopharmacology. Curr Pharm Des 2009, 15:2603-2614. 10.2174/138161209788957465, 19689331.
42. Gonzalez-Pinto A, Alberich S, Barbeito S, Gutierrez M, Vega P, Ibanez B, Haidar MK, Vieta E, Arango C. Cannabis and first-episode psychosis: different long-term outcomes depending on continued or discontinued use. Schizophr Bull 2011, 37:631-639. 10.1093/schbul/sbp126, 3080669, 19915168.
43. Kavanagh DJ, Waghorn G, Jenner L, Chant DC, Carr V, Evans M, Hemnan H, Jablensky A, McGrath JJ. Demographic and clinical correlates of comorbid substance use disorders in psychosis: multivariate analyses from an epidemiological sample. Schizophr Res 2004, 66:115-124. 10.1016/S0920-9964(03)00130-0, 15061243.
44. Hanssen M, Bak M, Bijl R, Vollebergh W, van Os J. The incidence and outcome of subclinical psychotic experiences in the general population. British Journal of Clinical Psychology 2005, 44:181-191. 10.1348/014466505X29611, 16004653.
45. Lincoln TM. Relevant dimensions of delusions: continuing the continuum versus category debate. Schizophrenia Research 2007, 93:211-220. 10.1016/j.schres.2007.02.013, 17398072.
46. van Os J, Linscott RJ, Myin-Germeys I, Delespaul P, Krabbendam L. A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder. Psychological Medicine 2009, 39:179-195.
47. Kelleher I, Cannon M. Psychotic-like experiences in the general population: characterizing a high-risk group for psychosis. Psychological Medicine 2010, 1-6.
48. van Os J, Hanssen M, Bijl RV, Ravelli A. Strauss (1969) revisited: a psychosis continuum in the general population?. Schizophrenia Research 2000, 45:11-20. 10.1016/S0920-9964(99)00224-8, 10978868.